TRCT
ACA icon

Tower Research Capital (TRC)’s Arcosa ACA Stock Holding History

Tower Research Capital (TRC)’s Portfolio ACA Stock Details ACA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$378K Buy
3,564
+2,002
+128% +$228K 0.01% 1127
2025
Q4 		$166K Sell
1,562
-362
-19% -$36.5K ﹤0.01% 1577
2025
Q3 		$180K Sell
1,924
-5,032
-72% -$468K 0.01% 1550
2025
Q2 		$603K Buy
6,956
+3,895
+127% +$326K 0.02% 833
2025
Q1 		$236K Sell
3,061
-2,265
-43% -$208K 0.01% 1274
2024
Q4 		$515K Buy
5,326
+2,699
+103% +$271K 0.01% 1040
2024
Q3 		$249K Sell
2,627
-7,109
-73% -$621K 0.01% 1416
2024
Q2 		$812K Buy
9,736
+8,801
+941% +$733K 0.01% 926
2024
Q1 		$80.3K Sell
935
-12,613
-93% -$1.03M ﹤0.01% 1959
2023
Q4 		$1.12M Buy
13,548
+10,160
+300% +$746K 0.01% 781
2023
Q3 		$244K Buy
3,388
+960
+40% +$72.8K 0.01% 1310
2023
Q2 		$184K Buy
2,428
+870
+56% +$58.5K 0.01% 1618
2023
Q1 		$98K Buy
1,558
+1,183
+315% +$69.4K ﹤0.01% 1885
2022
Q4 		$21K Sell
375
-3,153
-89% -$187K ﹤0.01% 3071
2022
Q3 		$202K Sell
3,528
-167
-5% -$9.26K ﹤0.01% 1919
2022
Q2 		$171K Buy
3,695
+3,283
+797% +$172K ﹤0.01% 1884
2022
Q1 		$24K Sell
412
-2,600
-86% -$134K ﹤0.01% 3349
2021
Q4 		$159K Sell
3,012
-889
-23% -$47.5K ﹤0.01% 1927
2021
Q3 		$195K Sell
3,901
-794
-17% -$41.1K 0.01% 1844
2021
Q2 		$276K Sell
4,695
-3,753
-44% -$232K 0.01% 1675
2021
Q1 		$550K Buy
8,448
+3,207
+61% +$197K 0.01% 1161
2020
Q4 		$288K Sell
5,241
-30,704
-85% -$1.57M 0.01% 1423
2020
Q3 		$1.58M Buy
35,945
+31,465
+702% +$1.38M 0.02% 558
2020
Q2 		$189K Buy
4,480
+4,152
+1,266% +$160K 0.01% 1830
2020
Q1 		$13K Buy
328
+219
+201% +$9.26K ﹤0.01% 1900
2019
Q4 		$5K Sell
109
-190
-64% -$7.31K ﹤0.01% 2665
2019
Q3 		$10K Sell
299
-6,054
-95% -$210K ﹤0.01% 2910
2019
Q2 		$239K Buy
6,353
+5,702
+876% +$195K 0.02% 790
2019
Q1 		$20K Buy
651
+72
+12% +$2.2K ﹤0.01% 2258
2018
Q4 		$16K Buy
+579
New +$15.9K ﹤0.01% 2092

Other funds holding ACA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Tower Research Capital (TRC)'s ACA Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Arcosa (ACA) stake by 128% in Q1 2026, buying an estimated $228K and bringing the position to 3,564 shares worth $378K. The position accounts for 0.01% of the portfolio, ranked #1127.

Tower Research Capital (TRC) first reported a position in ACA in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.58M in Q3 2020. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.

  • Tower Research Capital (TRC) held 3,564 shares of Arcosa worth $378K as of Q1 2026.
  • Tower Research Capital (TRC) bought 2,002 Arcosa shares in Q1 2026, an estimated $228K.
  • Arcosa made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1127 holding.
  • Tower Research Capital (TRC) first reported a position in Arcosa in Q4 2018 and has held it in 30 quarters since.
  • Tower Research Capital (TRC)'s Arcosa position peaked at $1.58M in Q3 2020.
  • 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.